HRTX
Heron Therapeutics, Inc.
$2.64
Earnings Summary
Revenue | $34.23Mn |
Net Profits | $-10.72Mn |
Net Profit Margins | -31.33% |
Highlights
Heron Therapeutics, Inc.’s revenue jumped 14% since last year same period to $34.23Mn in the Q4 2023. On a quarterly growth basis, Heron Therapeutics, Inc. has generated 8.9% jump in its revenue since last 3-months.
Heron Therapeutics, Inc.’s net profit jumped 60.59% since last year same period to $-10.72Mn in the Q4 2023. On a quarterly growth basis, Heron Therapeutics, Inc. has generated 57.12% jump in its net profits since last 3-months.
Heron Therapeutics, Inc.’s net profit margin jumped 65.43% since last year same period to -31.33% in the Q4 2023. On a quarterly growth basis, Heron Therapeutics, Inc. has generated 60.62% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Heron Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Current Year | -0.09 |
Highlights
Heron Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.09 - a 43.75% jump from last quarter’s estimates.
Heron Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.09.
Key Ratios
Key ratios of the Heron Therapeutics, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.07 |
Highlights
Heron Therapeutics, Inc.’s earning per share (EPS) jumped 58.82% since last year same period to -0.07 in the Q4 2023. This indicates that the Heron Therapeutics, Inc. has generated 58.82% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-09-30 | -0.29 | -0.17 | 41.38% |
2023-08-14 | -0.23 | -0.35 | -52.17% |
2023-05-11 | -0.2 | -0.27 | -35% |
2024-03-12 | -0.16 | -0.07 | 56.25% |
₹0 US Stocks a/c Opening Fee